1. Toll-like receptor 2-modulating pectin-polymers in alginate-based microcapsules attenuate immune responses and support islet-xenograft survival.
- Author
-
Hu, Shuxian, Kuwabara, Rei, Navarro Chica, Carlos E., Smink, Alexandra M., Koster, Taco, Medina, Juan D., de Haan, Bart J., Beukema, Martin, Lakey, Jonathan R.T., García, Andrés J., and de Vos, Paul
- Subjects
- *
PECTINS , *TOLL-like receptors , *IMMUNE response , *INFLAMMATION , *ISLANDS of Langerhans , *TYPE 1 diabetes - Abstract
Encapsulation of pancreatic islets in alginate-microcapsules is used to reduce or avoid the application of life-long immunosuppression in preventing rejection. Long-term graft function, however, is limited due to varying degrees of host tissue responses against the capsules. Major graft-longevity limiting responses include inflammatory responses provoked by biomaterials and islet-derived danger-associated molecular patterns (DAMPs). This paper reports on a novel strategy for engineering alginate microcapsules presenting immunomodulatory polymer pectin with varying degrees of methyl-esterification (DM) to reduce these host tissue responses. DM18-pectin/alginate microcapsules show a significant decrease of DAMP-induced Toll-Like Receptor-2 mediated immune activation in vitro , and reduce peri-capsular fibrosis in vivo in mice compared to higher DM-pectin/alginate microcapsules and conventional alginate microcapsules. By testing efficacy of DM18-pectin/alginate microcapsules in vivo , we demonstrate that low-DM pectin support long-term survival of xenotransplanted rat islets in diabetic mice. This study provides a novel strategy to attenuate host responses by creating immunomodulatory capsule surfaces that attenuate activation of specific pro-inflammatory immune receptors locally at the transplantation site. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF